相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
Qiang You et al.
HEPATOLOGY (2008)
STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo
Michael Quigley et al.
JOURNAL OF IMMUNOLOGY (2008)
Complement is an essential component of the immune response to adeno-associated virus vectors
Anne K. Zaiss et al.
JOURNAL OF VIROLOGY (2008)
The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver
Anton P. McCaffrey et al.
MOLECULAR THERAPY (2008)
AAV as an immunogen
Luk H. Vandenberghe et al.
CURRENT GENE THERAPY (2007)
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo
Chengwen Li et al.
JOURNAL OF VIROLOGY (2007)
Toll-like receptors and type I interferons
Satoshi Uematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator
Marcelo Nociari et al.
JOURNAL OF VIROLOGY (2007)
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways
Jiangao Zhu et al.
JOURNAL OF VIROLOGY (2007)
Type IIFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus
Jiangao Zhu et al.
JOURNAL OF IMMUNOLOGY (2007)
Cutting edge: Antibody-mediated TLR7-dependent recognition of viral RNA
Jennifer P. Wang et al.
JOURNAL OF IMMUNOLOGY (2007)
Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets
Lili Wang et al.
HUMAN GENE THERAPY (2007)
IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice
Annette Erhardt et al.
HEPATOLOGY (2007)
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy
Zejing Wang et al.
HUMAN GENE THERAPY (2007)
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
Cristiana Guiducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Luk H. Vandenberghe et al.
NATURE MEDICINE (2006)
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Paul Gregorevic et al.
NATURE MEDICINE (2006)
Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells
ML Shinohara et al.
NATURE IMMUNOLOGY (2006)
IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9
K Hoshino et al.
NATURE (2006)
Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice
CD Scallan et al.
BLOOD (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Translating innate immunity into immunological memory: Implications for vaccine development
B Pulendran et al.
CELL (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response
DB Stetson et al.
IMMUNITY (2006)
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA
KJ Ishii et al.
NATURE IMMUNOLOGY (2006)
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
DE Sabatino et al.
MOLECULAR THERAPY (2005)
Toll-like, receptor 8-mediated reversal of CD4+ regulatory T cell function
GY Peng et al.
SCIENCE (2005)
Immune responses to adeno-associated virus vectors
AK Zaiss et al.
CURRENT GENE THERAPY (2005)
Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction
K Honda et al.
NATURE (2005)
Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high-dose self-antigen
XP Huang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Recognition of single-stranded RNA viruses by Toll-like receptor 7
JM Lund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Plasmacytoid dendritic cells in immunity
M Colonna et al.
NATURE IMMUNOLOGY (2004)
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain
CS Peden et al.
JOURNAL OF VIROLOGY (2004)
Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance
YP Yang et al.
NATURE IMMUNOLOGY (2004)
Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells
A Izaguirre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways
K Hoebe et al.
NATURE IMMUNOLOGY (2003)
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
A Le Bon et al.
NATURE IMMUNOLOGY (2003)
Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection
K Honda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effect of suppressive DNA on CpG-induced immune activation
H Yamada et al.
JOURNAL OF IMMUNOLOGY (2002)
A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies
JA Wagner et al.
HUMAN GENE THERAPY (2002)
Factors influencing the development of an anti-factor IX (FIX) response following administration of adeno-associated virus-FIX
Y Ge et al.
BLOOD (2001)
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
KQ Xin et al.
HUMAN GENE THERAPY (2001)
Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
AM Douar et al.
JOURNAL OF VIROLOGY (2001)
Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column
A Auricchio et al.
HUMAN GENE THERAPY (2001)
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors
A Sarukhan et al.
JOURNAL OF VIROLOGY (2001)
BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
A Dzionek et al.
JOURNAL OF IMMUNOLOGY (2000)
Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors
WD Xiao et al.
MOLECULAR THERAPY (2000)
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
N Chirmule et al.
JOURNAL OF VIROLOGY (2000)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
DW Liu et al.
JOURNAL OF VIROLOGY (2000)
分享论文
